-
Patient Safety and Pharmacovigilance in Bangladesh
-
Google Joins the Pharmaceutical Industry
-
AstraZeneca gets an additional FDA approval for its diabetes drug
-
Pepsi admits its soda contains cancer-causing ingredients
-
Treatment with long term, low dose antibiotic could help people born with chronic lung con...
-
FDA OKs Trifarotene, First New Retinol Acne Cream in 20 Years
-
Strong Link Between Vitamin D Deficiency and Vastly Increased Risk of Premature Death
-
FDA approves first oral GLP-1 treatment for type 2 diabetes
-
FDA OKs Canagliflozin to Curtail Diabetic Kidney Disease
-
DGDA temporarily bans Ranitidine in Bangladesh
-
After GSK, Sanofi decides on wind-up
-
Aggressive drug-resistant malaria spreading in south-east Asia
-
FDA approves new treatment for complicated urinary tract and complicated intra-abdominal i...
-
FDA approves first treatment for chronic rhinosinusitis with nasal polyps
-
Linagliptin Safe in Diabetes Across Age, Renal Groups
-
New JAK Inhibitor Hits Rheumatoid Arthritis Targets
-
Statins may double the risk of type 2 diabetes
-
EMA facilitates early engagement with medicine developers to combat antimicrobial resistan...
-
Study of Vitamin D Deficiency among the Apparently Healthy Population in Jashore, Banglade...
-
FDA Approves First Vaccine for Dengue, With Restrictions
-
Excess Vitamin D Linked to Kidney Damage
-
Alcohol abuse kills 3 million a year, most of them men: WHO
-
FDA approves device for treatment of acute coronary artery perforations
-
The FDA Just Approved Two HIV Drugs: Will This Change Treatment?